Lower Prices, Rather Than Deep Rebates, Preferred For New Drugs – Hassan
Executive Summary
When launching new products, manufacturers should set lower prices rather than offer deep rebates, Schering-Plough CEO Fred Hassan said in an interview with "The Pink Sheet."